Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube, and peritoneal cancers
Ferriss, J.S., Java, J., Burger, R.A., Bookman, M.A., Fleming, G., Monk, B.J., Walker, J.L., Homesley, H.D., Fowler, J.M., Greer, B.E., Boente, M.P.Volume:
133
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.03.082
Date:
June, 2014
File:
PDF, 54 KB
english, 2014
File converter
More search results
More benefits 
